Medication Administration Guides

ACTEMRA (IV)

Tocilizumab

ADZYNMA (IV)

​

ARALAST NP (IV)

​

AVSOLA (IV)

Infliximab-axxq

BENLYSTA (IV)

​

BERINERT (IV)

​

BLINCYTO (IV)

Blinatumomab

BRIUMVI (IV)

​

CIMZIA (SC)

Certolizumab pegol

CRYSVITA (SC)

burosumab-twza

DALVANCE (IV)

​

DESFERAL (SC)

Deferoxamine

ELFABRIO (IV)

​

ENTYVIO (IV)

Vedolizumab

ETHANOL LOCK (IV)

​

EVKEEZA (IV)

​

FABRAZYME (IV)

agalsidase beta

FERAHEME (IV)

​

GLASSIA (IV)

​

HEMLIBRA (SC)

Emicizumab-kxwh

HYQVIA (SC)

IgG-hyaluronidase, Recombinant

IMAAVY (IV)

nipocalimab-aahu

IMMUNOGLOBULIN (IV)

​

INFLECTRA (IV)

Infliximab-dyyb

NULOJIX (IV)

Belatacept

OCREVUS (IV)

Ocrelizumab

ORENCIA (IV)

Abatacept

PROLASTIN (IV)

​

REMICADE (IV)

Infliximab

RENFLEXIS (IV)

Infliximab-abda

REZZAYO (IV)

rezafungin

RITUXAN (IV)

Rituximab

RUCONESST (IV)

C1 esterase inhibitor (recombinant)

RYSTIGGO (SC)

Rozanoloixizumab-noli

SAPHNELO (IV)

Anifrolumab-fnia

SIMPONI ARIA (IV)

Golimuumab

SKYRIZI (IV)

Risankizumab-rzaa

SOLIRIS (IV)

Eculizumab

SOLUMEDROL (IV)

Methylprednisolone

STELARA (IV)

Ustekinumab

TEPEZZA (IV)

Teprotumumab-trbw

TROGARZO (IV)

Ibalizumab-uiyk

TYSABRI (IV)

Natalizumab

VIMIZIM (IV)

elosulfase alfa

VYEPTI (IV)

Eptinezumab-jjmr

VYVGART (IV)

efgartigimod alfa-fcab

VYVGART HYTRULO (PFS)

efgartigimod alfa and hyaluronidase-qvfc

VYVGART HYTRULO (SC)

efgartigimod alfa and hyaluronidase-qvfc

ZOMETA (IV)

Zoledronic Acid